Sunshine Biopharma, Inc·4/A

Oct 7, 8:55 AM ET

MERZOUKI ABDERRAZZAK 4/A

4/A · Sunshine Biopharma, Inc · Filed Oct 7, 2019

Insider Transaction Report

Form 4/AAmended
Period: 2018-06-20
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2018-06-20$0.00/sh+27,000,000$27,00079,000,000 total

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT